North Carolina Approves Reimbursement of VR Therapy for Neurodivergent Residents Under NC Innovations Waiver

NEWS PROVIDED BY

Floreo

Sep 01, 2026, 00:01 ET

SHARE THIS ARTICLE

Under the state's NC Innovations Waiver, eligible families in Alliance Health's seven-county region can now request Floreo's virtual reality therapy platform through their care manager.

CHEVY CHASE, Md., Sept. 1, 2026 /PRNewswire/ -- North Carolina has approved Medicaid Waiver reimbursement for virtual reality (VR) services delivered by Floreo – the pioneering developer of VR-based therapy – for neurodivergent youth and adults supported by the NC Innovations Waiver.

The state's NC Innovations Waiver covers a wide range of home and community-based supports for individuals with intellectual or development disabilities— from help with daily living activities and job coaching to assistive technology and caregiver support. The NC Innovations waiver is an NC Medicaid program that "waives" (does not consider) some of the usual Medicaid eligibility requirements, like the family's income. Any North Carolinian with autism or other intellectual and development disabilities can apply regardless of age or insurance status.

"North Carolina has shown a real commitment to practical, access-oriented support for the neurodivergent community, and this expansion of the NC Innovations Waiver is a great example," said Vijay Ravindran, CEO and founder of Floreo. "As a result, many neurodivergent individuals across the state will now have a new, tangible way to build the confidence and independence they need for everyday life."

Floreo's approval as a vendor applies to the seven counties managed by Alliance Health: Cumberland, Durham, Harnett, Johnston, Mecklenburg, Orange, and Wake, the state's most populous county. North Carolina families in this region who are eligible for the NC Innovations Waiver can now request reimbursement for Floreo's VR therapy platform directly through their Care Manager.

Floreo helps neurodivergent youth and adults build social, behavioral, and daily life skills by practicing real-world scenarios — like navigating public transportation, interacting with law enforcement, multi-tasking at work, or raising a hand to answer a question in the classroom — in a safe, immersive virtual environment. North Carolina joins a growing list of states that provide Medicaid waiver reimbursement for Floreo's services, including Tennessee, New York, and Wisconsin.

As the first VR autism technology to receive the Food and Drug Administration's (FDA) breakthrough device designation, Floreo is backed by a growing body of research conducted with world-renowned programs like the Center for Autism Research at the Children's Hospital of Philadelphia and the National Institutes of Health. Floreo's VR curriculum augments traditional therapies and improves outcomes for neurodivergent individuals and individuals with developmental disabilities.

Families and care providers in the Alliance Health region interested in incorporating Floreo into a support plan should contact their care manager to learn more.

About Floreo

Floreo's vision is a world that is open and accessible for every neurodiverse person. Through immersive virtual reality experiences, Floreo creates safe, engaging environments where learners can build skills and tools they can apply in their everyday lives. Floreo's virtual reality platform teaches social, behavioral, communication, and life skills for individuals with Autism Spectrum Disorder and other neurodiverse conditions. For more information, please visit floreovr.com.

SOURCE Floreo

21%

more press release views with 

Request a Demo

Ashley Williams and Nikki DeLoach to Host Annual Dance Party to End ALZ Benefiting the Alzheimer's Association

NEWS PROVIDED BY

Alzheimer’s Association

Sep 01, 2026, 00:01 ET

SHARE THIS ARTICLE

—– Jonathan Bennett and Melissa Peterman to Emcee Star-Studded Pajama Party-Themed Fundraiser Supporting Alzheimer's Research —–

Expected performers include Caleb Polaha, Eliza Pryor, Greg Laswell, Holly Robinson Peete, Karen David, Kayden Muller-Janssen, Lindsey Gort, Melinda Doolittle, Paul Greene, Riley Weston, Sarah Drew and Tamera Mowry-Housley

LOS ANGELES, Sept. 1, 2026 /PRNewswire/ -- Hallmark stars Ashley Williams and Nikki DeLoach will host the eighth annual Dance Party to End ALZ on Sunday, Sept. 13, at AVALON Hollywood, bringing together celebrities, advocates and supporters for an unforgettable evening benefiting the Alzheimer's Association's research grant program.

Founded by Kimberly Williams-Paisley in honor of her mother and family's journey with Alzheimer's disease, the signature fundraiser has become a beloved annual event dedicated to accelerating scientific breakthroughs and advancing hope for millions of families affected by dementia.

This year's Pajama Party-themed celebration will be emceed by Jonathan Bennett and Melissa Peterman and will feature live musical performances, special celebrity appearances, dancing, auctions and inspiring mission-focused moments highlighting the urgent need for Alzheimer's and dementia research.

Williams and DeLoach, who have both experienced the loss of a parent to dementia, will welcome guests for an evening centered on remembrance, community and action.

"Every year, this event reminds us of the incredible power of community," said Williams and DeLoach. "So many families, including our own, have been impacted by Alzheimer's and other forms of dementia. Dance Party to End ALZ allows us to honor our loved ones while raising critical funds for groundbreaking research that brings us closer to a world without Alzheimer's."

Accompanied by Casual Encounters, expected performers include:

Caleb Polaha

Eliza Pryor

Greg Laswell

Holly Robinson Peete

Karen David

Kayden Muller-Janssen

Lindsey Gort

Melinda Doolittle

Paul Greene

Riley Weston

Sarah Drew

Tamera Mowry-Housley

Guests are encouraged to embrace the event theme by arriving in pajamas, slippers and sleep masks for a pajama party with purpose. Throughout the evening, attendees will have opportunities to support the Alzheimer's Association through fundraising activities and learn more about the organization's efforts to advance research, improve care and provide support services for families facing Alzheimer's and other dementias.

Event Committee

Ashley Williams, actor, director and writer

Nikki DeLoach, actor, producer and writer

Annie Howell, chief communications officer, Hallmark Media

Shaina Julian, director of talent relations and events, Hallmark Media

Cassandra Troy, co-founder, Little West

Andrew Walker, actor, producer and co-founder, Skin Mason

Featured Sponsors

Hallmark Media

Kimberly Williams-Paisley & Brad Paisley

Funds raised through Dance Party to End ALZ support the Alzheimer's Association's research grant program, which invests in innovative studies focused on prevention, treatment and ultimately a cure for Alzheimer's disease and all other dementia.

Since its inception, Dance Party to End ALZ has raised more than $2 million to accelerate Alzheimer's research and help advance promising scientific discoveries. Organizers hope this year's event will build on that momentum while raising awareness of a disease that affects millions of families worldwide.

For tickets, sponsorship information or to make a donation, visit alz.org/DanceParty.

About the Alzheimer's Association ®

The Alzheimer's Association is a worldwide voluntary health organization dedicated to Alzheimer's care, support and research. Our mission is to lead the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer's and all other dementia®. Visit alz.org or call 800.272.3900.

SOURCE Alzheimer’s Association

21%

more press release views with 

Request a Demo

Eluvio to Power Pasifika+: New OTT TV Streaming Service to Reach Consumers Throughout the Pacific and Across the Globe

NEWS PROVIDED BY

Eluvio, Inc.

Sep 01, 2026, 00:01 ET

SHARE THIS ARTICLE

New Direct-to-Consumer OTT Service: New Zealand-based Pacific Cooperation Broadcasting Limited (PCBL), operator of Pasifika TV, has selected Eluvio for a new direct-to-consumer streaming service scheduled to launch later this year

A Platform with Purpose: Focusing on Pacific media sustainability and story sovereignty, content will come from the consortium of 30+ Pacific broadcasters and local content creators, backed by a revenue-share model that returns value directly to the region's media ecosystem

Built on Eluvio's Global Broadcast Fabric: New service to provide live and VOD distribution, monetization, and frame-accurate inline AI without file duplication or use of legacy media clouds and CDNs 

BERKELEY, Calif., Sept. 1, 2026 /PRNewswire/ -- Ahead of IBC Show 2026, Eluvio today announced that it was selected to power Pasifika+, a new direct-to-consumer streaming service for Pacific Cooperation Broadcasting Limited (PCBL), that will extend the collective reach of Pasifika TV and its media partners to Pacific Island communities and fans across the globe. Eluvio's Content Fabric will provide Pasifika+ with a unified zero-copy platform for broadcast, streaming and AI video intelligence from a single ingest workflow, without creating file copies at any stage, and superseding the use of legacy media clouds or CDNs. Specific details about pricing and availability of Pasifika+ will be made by PCBL later this year. 

Eluvio to Power Pasifika+:

Formed to strengthen partnerships between New Zealand and the Pacific Islands through television broadcasting, PCBL delivers Pasifika TV to a growing collective of more than 30 free-to-air broadcast partners across the Pacific. Pasifika+ will extend that mission via a direct-to-consumer streaming service globally for the first time. Pasifika+ aims to connect diaspora audiences in New Zealand, Australia, the U.S., and elsewhere back to their home islands, preserve and share Pacific culture, sport, news, and original entertainment, and provide the region's broadcasters and content creators a new, equitable revenue stream.

"Pasifika+ is a platform with purpose — it's about giving every fan of Pacific content, especially our diaspora, access to the unique stories, news, and entertainment to stay connected to home, while opening a new, equitable revenue stream back to the 30+ broadcasters and local content creators who make our stories possible. Beyond entertainment value, Pasifika+ will provide our regional media partners with a powerful new way to advocate for self-determination, sovereignty, and government accountability, while educating the rest of the world about the beauty of and issues facing Pacific island nations," said Natasha Meleisea, Chief Executive Officer, PCBL. "Therefore, after evaluating numerous alternatives, we selected Eluvio because they aligned with our aspirations, had the most cost-effective, easy-to-use, and technologically advanced platform to securely scale into a global operation, while providing us a level of monetization and viewer insights never before possible. We look forward to partnering with Eluvio to launch Pasifika+ in the months ahead."

"PCBL is a mission-driven organization with the trust of Pacific broadcasters, regional production companies, and content creators, and we're honored that the Eluvio Content Fabric, serving as a Global Broadcast Fabric, will enable them to distribute and monetize their exceptional regional news, sports, documentaries, and entertainment globally for the first time," said Michelle Munson, CEO and Co-founder, Eluvio. "In addition to traditional live and VOD programming, Pasifika+ will also deploy our Inline AI services to expand their content pipeline, using Eluvio's AI-enabled analysis, clipping, search, and content composition, to scale efficiently from day one without requiring additional original production. For an organization carrying this much cultural and economic responsibility, having zero-copy distribution, monetization, and AI unified on a single platform isn't just efficient, it gives PCBL the freedom to focus on their audiences and creators well into the future."

A Unified Platform for Streaming and AI Video Intelligence

Eluvio's Content Fabric receives live or VOD source feeds and dynamically ingests, transcodes, publishes and generates just-in-time streaming output directly to viewers. Streaming is provided at full source resolution, including HD and 4K, with dynamic automatic adaptation to the user's available bandwidth with low latency HLS/DASH delivery, unlimited multi-view, and "zero-copy" live-to-VoD and fast DVR playback. Pasifika TV will provide a white-label browser, mobile, and connected TV application to its viewers built using the Eluvio Media Wallet platform (full turnkey OTT Suite). The platform also provides subscriptions, pay-per-view, and/or ad-supported monetization, while providing end-to-end content security and anti-piracy protection including strong encryption, DRM, forensic watermarking, and dynamic authorization per-offering including geo blocking and rights control. All features are built-in allowing for a hyper-efficient, tamper-proof distribution, fast and easy purchasing, and on-screen authenticity proofs for the viewer.

In addition, the Eluvio Video Intelligence Editor (EVIE) and AI-assisted tools provide frame-accurate, in-line analysis, indexing, and search, composition, and transformation such as live vertical video, all without file copies or re-transcoding. Finally, Eluvio Content Analytics provides complete transparency of source-to-viewer audience, QoS, and sales analytics. Full details about Eluvio's technical capabilities and benefits can be found at https://eluv.io.

Eluvio at IBC Show 2026

During IBC Show 2026 at the RAI Amsterdam, Eluvio will highlight its work with Pasifika+ and showcase the full capabilities of the Global Broadcast Fabric and Eluvio AI and in Hall 8, Stand 8.MS5, and in the Future Tech Zone, Hall 14, Stand 14.A58, September 11–14, 2026. In addition, Eluvio's CEO and co-founder, Michelle Muson, will also speak on the Future Tech Zone stage on Sunday, September 13 from 2pm-2:15pm. Registration for one-on-one meetings and information about Eluvio on-site keynote demonstrations at IBC is available at https://ibc.eluv.io.

About Eluvio

Eluvio (https://eluv.io) is solving the generational problems of video over the Internet with its Content Fabric Protocol — transforming the distribution and monetization of premium video and digital media in contrast to legacy cloud workflows and CDNs. Eluvio serves Amazon Studios/MGM, Cricket Australia, European Professional Club Rugby, FOX, SONY, Telstra Broadcast Services, UEFA, United Rugby Championship, Warner Bros., WPALiveTV, WWE, and others. Led by Michelle Munson and Serban Simu, founders and inventors of Aspera, and based in Berkeley, California. Eluvio holds more than 15 issued US patents and has won multiple NAB Streaming Product of the Year awards, the Seicon Grand Prize, Hollywood Professional Association Engineering Excellence Award, and other industry honors. @EluvioInc | linkedin.com/company/eluv-io

About Pacific Cooperation Broadcasting Limited (PCBL)

Pacific Cooperation Broadcasting Limited (PCBL) was established in April 2015. It is a New Zealand initiative that is primarily funded by the Ministry of Foreign Affairs and Trade with the overall aim to deepen partnerships in the Pacific region by strengthening the media sector. PCBL supports Pacific free-to-air broadcasters through delivering New Zealand and Pacific originated content that can be rebroadcast to their local audiences and encouraging the production of local content via the provision of field equipment, network infrastructure, contestable funding and training. 

SOURCE Eluvio, Inc.

21%

more press release views with 

Request a Demo

United States Government and North American Blue Energy Partners (NABEP) Reach Historic Deal to Develop Venezuela's Oil Sector

NEWS PROVIDED BY

North American Blue Energy Partners (NABEP)

Aug 31, 2026, 23:34 ET

SHARE THIS ARTICLE

The deal, made possible by strengthening relations between Venezuela and the United States, is expected to involve nearly $100 billion in investment to commercialize more than 65 billion barrels of P1 reserves in Venezuela.

CARACAS, Venezuela, Aug. 31, 2026 /PRNewswire/ -- The United States Departments of State and War have reached an historic deal with North American Blue Energy Partners (NABEP) to significantly expand oil production in Venezuela. As part of the deal, NABEP will have operating control of the business, with the United States Government holding rights to a 35% stake in the company, alongside preferential access to 20% of the company's production at cost.

President Donald J. Trump announced the agreement on Truth Social as "the biggest oil deal in world history" and is demonstrative of the U.S. and Venezuelan governments deepening collaboration in the Venezuelan oil sector, bringing jobs and fiscal stability for Venezuelans and lower prices at the pump for Americans.

"Venezuela is blessed with an abundance of natural resources, hardworking people and untapped potential," said Alejandro Betancourt, CEO of NABEP. "This transaction will unleash that potential to the great benefit of both Venezuelans and Americans. We are grateful to President Donald J. Trump, Secretary Marco Rubio, Secretary Pete Hegseth, the United States Government, and to President Delcy Rodríguez and the Government of Venezuela, for their confidence in NABEP and their willingness to tackle this challenge with us. We look forward to pioneering a new and exciting path together."

This new venture is expected to bring tens of millions of additional barrels of Venezuelan oil to the global marketplace, thousands of well-paid jobs to Venezuela, and billions in incremental investment and broader economic activity to drive growth in Venezuela's recovering economy. Through the right to purchase 20% of the oil produced at cost, this venture will also ultimately deliver billions in savings for American consumers and secure a stable and growing strategic supply of oil in the Western Hemisphere. Through billions in purchases of oil infrastructure and equipment from U.S. suppliers, NABEP will also support thousands of manufacturing jobs in the United States.

Mr. Betancourt has been in the Venezuelan oil industry for more than 15 years with a consistent track record of success, most recently at the helm of NABEP, where he rapidly scaled the company's production from approximately 18,000 barrels per day to more than 200,000 barrels per day through roughly $1 billion in company-funded investment, making it the country's second-largest oil producer in just two years' time. Today, the company directly employs over 5,000 people and supports over 10,000 contractor employees across Venezuela.

Following these transactions, NABEP now controls the rights to commercialize more than 65 billion barrels of P1 reserves in Venezuela. NABEP is seeking to rapidly expand its operations in Lake Maracaibo and the Orinoco Belt with the near-term goal of increasing production to more than 1 million barrels of oil per day.

As it was announced, the program will involve nearly $100 billion in investment to increase production capacity and oil and gas infrastructure in Venezuela and will generate more than $209 billion in tax revenue for the Venezuelan state.

In a statement posted to X immediately following the announcement, U.S. Secretary of State Marco Rubio said: "This deal is a huge win for both the American and Venezuelan people. It demonstrates how President Trump's bold foreign policy is driving America First wins: securing stable reserves and low-cost oil in our Hemisphere and lowering gas prices here at home. For the Venezuelan people, this deal will bring nearly $100 billion in private investment, support thousands of high-paying jobs, and drive the reconstruction of Venezuela's economy."

About North American Blue Energy Partners

North American Blue Energy Partners (NABEP) is an independent oil exploration and production company operating in North and Latin America, with offices in Caracas, Maracaibo and Lechería. NABEP is committed to the responsible development of energy resources, the safety of its people, and the prosperity of the communities where it operates. www.nabep.net

Media contact

press@nabep.com

SOURCE North American Blue Energy Partners (NABEP)

21%

more press release views with 

Request a Demo

H.I.G. Capital Expands Its Capital Formation Team with Younghee Choi as Head of Asia USA - English

NEWS PROVIDED BY

H.I.G. Capital

Sep 01, 2026, 00:00 ET

SHARE THIS ARTICLE

HONG KONG, Sept. 1, 2026 /PRNewswire/ -- H.I.G. Capital ("H.I.G."), a leading global alternative investment firm with $75 billion of capital under management, is pleased to announce that Younghee Choi has joined the firm's Capital Formation Group as Head of Asia. Younghee is based in Hong Kong and will lead capital formation efforts across Asia for H.I.G.'s global private equity, credit, and real assets platforms.

With more than 15 years of experience in capital formation and private markets, Younghee joins H.I.G. from Blackstone, where she held senior roles across the firm's Institutional Client Solutions ("ICS") and Private Wealth businesses, serving as Senior Managing Director and Head of Korea ICS. During her tenure at Blackstone, Younghee developed and expanded relationships with a broad base of leading institutional investors and played a key role in building the firm's private wealth fundraising business in Korea.

Jordan Peer Griffin, Executive Managing Director and Global Head of the Capital Formation Group, commented: "We are pleased to welcome Younghee to H.I.G. Her extensive capital formation experience, longstanding relationships across Asia, and ability to build enduring partnerships with institutional and private wealth investors will further strengthen our presence in the region. Younghee's leadership will be instrumental as we expand our Asian LP base and support the continued growth of H.I.G.'s global investment platforms."

Younghee Choi, Head of Asia, also commented: "I am thrilled to join H.I.G. at such an exciting time in the firm's growth. I look forward to working closely with the team to deepen our relationships with investors across Asia, broaden H.I.G.'s presence in the region, and connect our investors with the full breadth of the firm's global capabilities."

About H.I.G. Capital

H.I.G. is a leading global alternative investment firm with $75 billion of capital under management.* Based in Miami, and with offices in Atlanta, Boston, Chicago, Los Angeles, New York, San Francisco, and Stamford in the United States, as well as international affiliate offices in Hamburg, London, Luxembourg, Madrid, Milan, Paris, Bogotá, Rio de Janeiro, Dubai, and Hong Kong. H.I.G. specializes in providing both debt and equity capital to middle market companies, utilizing a flexible and operationally focused/value-added approach:

H.I.G.'s equity funds invest in management buyouts, recapitalizations, and corporate carve-outs of both profitable as well as underperforming manufacturing and service businesses.

H.I.G.'s debt funds invest in senior, unitranche, and junior debt financing to companies across the size spectrum, both on a primary (direct origination) basis, as well as in the secondary markets.

H.I.G.'s real estate funds invest in value-added properties, which can benefit from improved asset management practices.

H.I.G. Infrastructure focuses on making value-add and core plus investments in the infrastructure sector.

Since its founding in 1993, H.I.G. has invested in and managed more than 400 companies worldwide. The Firm's current portfolio includes more than 100 companies with combined sales in excess of $53 billion. For more information, please refer to the H.I.G. website at hig.com.

*Based on total capital raised by H.I.G. Capital and its affiliates.

Contact:

Media Relations

media@hig.com

H.I.G. Capital Hong Kong, Ltd.

Suite 3106, Level 31, Alexandra House

18 Chater Road, Central,

Hong Kong, China

Phone: +852 2707 5000

hig.com

21%

more press release views with 

Request a Demo

Orexo reaches non-binding agreement in principle to settle investigation by US Department of Justice USA - English

NEWS PROVIDED BY

Orexo

Aug 31, 2026, 23:41 ET

SHARE THIS ARTICLE

UPPSALA, Sweden, Aug. 31, 2026 /PRNewswire/ -- Orexo AB (publ) (STO: ORX) (OTCQX: ORXOY) today announced that the company has reached a non-binding agreement in principle on the main elements of a settlement with the US Department of Justice (DOJ). Orexo is in the last stages of concluding the final settlement agreement, which would close a DOJ investigation that has been ongoing since 2020. There can be no assurance that a final settlement will be entered into on the terms in this press release.

Under the agreement in principle, the company would agree to pay USD 4 million in installments over several years. The company would also agree to a capped contingent payment based on five percent of net sales conditioned on certain sales related threshold being met in 2030-2031, at a level where Orexo's commercial products are successful in the market. The final details of the settlement agreement will be disclosed in the event that a final settlement agreement is entered into with the DOJ.

The company's settlement would take the form of a Non-Prosecution Agreement (NPA) and a separate civil settlement. There would be no admission of wrongdoing by Orexo or any of its current or former employees. Once finalized, the NPA and civil settlement would resolve the DOJ investigation with respect to the matters covered by the agreements and there would be no more exposure for Orexo as a result of the investigation.

Orexo also understands that two former Orexo US employees have reached agreements in principle with the DOJ to resolve civil claims. The company intends to seek insurance coverage for the full settlement amount for the former employees. 

"The investigation by the Department of Justice has been on-going for more than 6 years. I am pleased that we are close to concluding the investigation. The decision to pursue a settlement is not an admission of any wrongdoing, but is based on the significant costs of a continued process and the need to focus on the continued development of Orexo and its important research," Nikolaj Sørensen, President and CEO of Orexo AB.

As a result of the progress with the US Department of Justice, Orexo is expected to recognise a provision for the expected liability of USD 4 million. Further information on the financial effects will be disclosed separately when a final settlement agreement is entered into with the DOJ.

For further information contact:

Nikolaj Sørensen, President and CEO

ir@orexo.com

About Orexo

Orexo is a Swedish pharmaceutical company dedicated to advance treatments for severe diseases and life-saving rescue medications to meet future healthcare needs. At the core of our innovation is AmorphOX®, a proprietary drug delivery technology that improves bioavailability and stability for both large and small molecules, enabling new approaches to administration, manufacturing, and distribution. With over 30 years of experience and multiple drugs approved globally, Orexo is advancing a diversified pipeline of programs in clinical and preclinical development. The company collaborates with partners in research, development, and commercialization. Headquartered in Uppsala, Sweden, Orexo is listed on Nasdaq Stockholm's main market and trades as ADRs on the OTCQX market in the United States.

For more information please visit www.orexo.com. You can also follow Orexo on X, LinkedIn, and YouTube.

This information is information that Orexo AB (publ.) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 8 pm CET on August 31st, 2026.

CONTACT:

Orexo

+46 (0)18 780 88 00

ir@orexo.se 

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/orexo/r/orexo-reaches-non-binding-agreement-in-principle-to-settle-investigation-by-us-department-of-justice,c4389960

The following files are available for download:

https://mb.cision.com/Main/694/4389960/4242885.pdf

Orexo - DOJ Press Release_Published August 31 2026

SOURCE Orexo

21%

more press release views with 

Request a Demo

Orexo reaches non-binding agreement in principle to settle investigation by US Department of Justice USA - English

NEWS PROVIDED BY

Orexo

Aug 31, 2026, 23:50 ET

SHARE THIS ARTICLE

UPPSALA, Sweden, Sept. 1, 2026 /PRNewswire/ -- Orexo AB (publ) (STO: ORX) (OTCQX: ORXOY) today announced that the company has reached a non-binding agreement in principle on the main elements of a settlement with the US Department of Justice (DOJ). Orexo is in the last stages of concluding the final settlement agreement, which would close a DOJ investigation that has been ongoing since 2020. There can be no assurance that a final settlement will be entered into on the terms in this press release.

Under the agreement in principle, the company would agree to pay USD 4 million in installments over several years. The company would also agree to a capped contingent payment based on five percent of net sales conditioned on certain sales related threshold being met in 2030-2031, at a level where Orexo's commercial products are successful in the market. The final details of the settlement agreement will be disclosed in the event that a final settlement agreement is entered into with the DOJ.

The company's settlement would take the form of a Non-Prosecution Agreement (NPA) and a separate civil settlement. There would be no admission of wrongdoing by Orexo or any of its current or former employees. Once finalized, the NPA and civil settlement would resolve the DOJ investigation with respect to the matters covered by the agreements and there would be no more exposure for Orexo as a result of the investigation.

Orexo also understands that two former Orexo US employees have reached agreements in principle with the DOJ to resolve civil claims. The company intends to seek insurance coverage for the full settlement amount for the former employees. 

"The investigation by the Department of Justice has been on-going for more than 6 years. I am pleased that we are close to concluding the investigation. The decision to pursue a settlement is not an admission of any wrongdoing, but is based on the significant costs of a continued process and the need to focus on the continued development of Orexo and its important research," Nikolaj Sørensen, President and CEO of Orexo AB.

As a result of the progress with the US Department of Justice, Orexo is expected to recognise a provision for the expected liability of USD 4 million. Further information on the financial effects will be disclosed separately when a final settlement agreement is entered into with the DOJ.

For further information contact:

Nikolaj Sørensen, President and CEO

ir@orexo.com

About Orexo

Orexo is a Swedish pharmaceutical company dedicated to advance treatments for severe diseases and life-saving rescue medications to meet future healthcare needs. At the core of our innovation is AmorphOX®, a proprietary drug delivery technology that improves bioavailability and stability for both large and small molecules, enabling new approaches to administration, manufacturing, and distribution. With over 30 years of experience and multiple drugs approved globally, Orexo is advancing a diversified pipeline of programs in clinical and preclinical development. The company collaborates with partners in research, development, and commercialization. Headquartered in Uppsala, Sweden, Orexo is listed on Nasdaq Stockholm's main market and trades as ADRs on the OTCQX market in the United States.

For more information please visit www.orexo.com. You can also follow Orexo on X, LinkedIn, and YouTube.

This information is information that Orexo AB (publ.) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 8 pm CET on August 31st, 2026.

CONTACT:

Orexo

+46 (0)18 780 88 00

ir@orexo.se 

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/orexo/r/orexo-reaches-non-binding-agreement-in-principle-to-settle-investigation-by-us-department-of-justice,c4389960

The following files are available for download:

https://mb.cision.com/Main/694/4389960/4242885.pdf

Orexo - DOJ Press Release_Published August 31 2026

21%

more press release views with 

Request a Demo

Hydreight Reports Record Q2 2026 Revenue of $28.0 Million, Net Income of $2.5 Million and Adjusted EBITDA of $3.2 Million

NEWS PROVIDED BY

Hydreight Technologies Inc.

Aug 31, 2026, 22:25 ET

SHARE THIS ARTICLE

Revenue increased 421% year-over-year as Hydreight delivered its strongest revenue quarter to date, with continued sequential growth in revenue and gross profit while maintaining strong profitability

Q2 2026 Highlights

Revenue of $28.0 million, an increase of 421% from $5.4 million in Q2 2025 and approximately 12.5% from Q1 2026

Gross profit of $5.4 million, an increase of 182% from $1.9 million in Q2 2025 and approximately 7% quarter over quarter

Net income of $2.5 million, compared with $0.05 million in Q2 2025

Adjusted EBITDA¹ of $3.2 million, compared with $0.2 million in Q2 2025

Six-month revenue of $53.0 million, an increase of 434% year-over-year

Six-month net income of $5.1 million

Working capital of $35.0 million at June 30, 2026

Cash of $20.0 million at June 30, 2026

VANCOUVER, BC and LAS VEGAS, Aug. 31, 2026 /PRNewswire/ -- Hydreight Technologies Inc. ("Hydreight" or the "Company") (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6), a U.S.-focused digital health infrastructure platform, is pleased to report its financial results for the three and six months ended June 30, 2026. All figures are in Canadian dollars unless otherwise stated.

Hydreight generated record second-quarter revenue of $28.0 million, representing an increase of 421% compared with $5.4 million in the second quarter of 2025. Adjusted Revenue¹ was $30.2 million, compared with $7.3 million in the prior-year period.

The Company generated gross profit of $5.4 million, net income of $2.5 million and Adjusted EBITDA¹ of $3.2 million during the quarter.

The second quarter also represented continued sequential growth from Q1 2026, with revenue increasing approximately 12.5% quarter-over-quarter and gross profit increasing approximately 7.0%, while net income and Adjusted EBITDA remained relatively consistent with Q1 levels.

For the six months ended June 30, 2026, Hydreight generated $53.0 million in revenue, an increase of 434% compared with $9.9 million during the same period in 2025, together with $5.1 million in net income and approximately $6.5 million in Adjusted EBITDA¹.

Three months ended June 30,  

%

Six months ended June 30,  

%

2026

2025

change

2026

2025

change

Adjusted Revenue

$        30,161,397

$     7,348,796

310 %

$    57,787,184

$    13,876,753

316 %

  Deduct - deferred business partner contract revenue 

-696,221

198,794

(549,666)

652,934

  Deduct - business partner payouts on app service gross revenue

2,823,210

1,773,483

5,371,791

3,307,178

GAAP Revenue

$        28,034,408

$     5,376,519

421 %

$    52,965,059

$      9,916,641

434 %

Adjusted Gross Margin

$          4,741,227

$     2,128,996

123 %

$      9,970,186

$      4,087,601

144 %

  Deduct - deferred business partner contract revenue 

-696,221

198,794

-549,666

652,934

GAAP Gross Margin

$          5,437,448

$     1,930,202

182 %

$    10,519,852

$      3,434,667

206 %

Adjusted EBITDA

$          3,220,299

$        181,971

$      6,481,137

$         345,383

  Deduct - amortization and depreciation

175,987

107,129

350,204

208,133

  Deduct - share-based payments

(4,882)

24,975

-

66,480

  Deduct - interest and accretion

483,767

-

951,330

-

  Deduct - sales tax provision, net cash paid

36,567

-

64,001

-

GAAP Net Income

$          2,528,860

$          49,867

$      5,115,602

$           70,770

SECOND QUARTER 2026 FINANCIAL HIGHLIGHTS

Hydreight's second-quarter revenue growth was primarily driven by continued scaling of the VSDHOne platform and related order flow, together with organic growth in new business partners, renewals from existing partners and additions to service offerings.

Pharmacy product sales increased to approximately $26.2 million during Q2 2026, compared with $4.5 million during Q2 2025.

The Company's virtual healthcare/direct-to-consumer segment generated approximately $22.8 million of revenue during Q2 2026, compared with approximately $0.7 million in Q2 2025. For the first six months of 2026, the segment generated approximately $42.7 million, compared with approximately $1.0 million during the corresponding period in 2025.

The Company's Q2 gross-margin percentage remained below the prior-year period primarily due to the significant increase in pharmacy sales as a percentage of total revenue and pricing concessions associated with initial transactions under several new supporting partnerships with compounding pharmacies. Hydreight generally aims to earn approximately a 20% margin on pharmacy sales before discounts and incentives, although individual product margins vary by product type, manufacturer and the timing of promotions.

Shane Madden, Chief Executive Officer of Hydreight, commented:

"Q2 was another record revenue quarter for Hydreight, with revenue reaching approximately $28.0 million compared with $5.4 million in the same period last year.

What I believe is equally important is what is happening underneath that growth. Compared with Q1, revenue increased approximately 12.5%, while gross profit increased approximately 7.0%, with net income and Adjusted EBITDA remaining relatively consistent with Q1 levels. We believe this combination of continued top-line growth and sustained profitability demonstrates the strength of the platform as we continue scaling the infrastructure we have spent years building.

Through the first six months of 2026, Hydreight generated approximately $53.0 million in revenue and $5.1 million in net income. VSDHOne and our virtual healthcare infrastructure have become significant contributors to our business, while we continue investing in the technology, pharmacy relationships, provider infrastructure and compliance capabilities needed to support additional scale.

We remain focused on execution. Our priorities for the remainder of 2026 are to continue increasing utilization across the platform, expand our partner and product ecosystem, invest in VSDHOne 2.0 and related technology, and continue building the infrastructure required to support the next stage of Hydreight's growth."

PLATFORM SCALE AND VSDHONE

Hydreight's growth continues to be supported by the expansion of its healthcare infrastructure across three principal verticals: mobile medical services, physical healthcare locations and virtual healthcare/direct-to-consumer services through VSDHOne.

During the six months ended June 30, 2026, the Company's virtual healthcare/direct-to-consumer segment generated approximately $42.7 million in revenue, compared with approximately $1.0 million in the corresponding period in 2025.

Hydreight continues to invest in VSDHOne 2.0, which is designed to enhance the Company's technology infrastructure to support scalability, security and long-term growth. During the first six months of 2026, the Company added approximately $0.8 million of development investment to VSDHOne 2.0.

The Company's broader infrastructure spans all 50 U.S. states and includes a network of more than 3,000 nurses, more than 300 independent doctors and pharmacy relationships supporting its healthcare ecosystem.

BALANCE SHEET AND GROWTH CAPITAL

Hydreight ended Q2 2026 with approximately $20.0 million in cash and $35.0 million in working capital, compared with $15.6 million in cash and $15.7 million in working capital at December 31, 2025.

During the first six months of 2026, Hydreight used approximately $8.7 million of cash in operating activities, primarily reflecting increased working capital deployed as the Company continued to scale its pharmacy operations and support new product and treatment lines.

Hydreight and its subsidiaries work with and support compounding pharmacies, both directly and indirectly, by providing funding and/or medical, formulation and structural support to establish new product and treatment lines. This enables greater control over pricing while helping ensure the appropriate inventory, operational, regulatory and compliance structures are in place.

This investment in working capital occurred alongside substantial growth in the Company's pharmacy operations. Pharmacy product sales increased to approximately $26.2 million in Q2 2026, compared with approximately $4.5 million in Q2 2025.

At June 30, 2026, Hydreight maintained approximately $20.0 million in cash and $35.0 million in working capital, providing the Company with financial resources to continue supporting its existing operations and strategic growth initiatives.

2026 OUTLOOK

Hydreight is reaffirming its previously announced fiscal 2026 revenue guidance of approximately $150 million, based on management's current internal planning assumptions.

The Company's previously issued guidance is based on expectations regarding partner activity, transaction volumes, service mix, capacity utilization across pharmacy operations and general market conditions. Actual results may differ materially, and the guidance remains subject to the assumptions and risks described under "Cautionary Note Regarding Forward-Looking Information."

Management continues to focus on increasing platform utilization, expanding strategic healthcare partnerships, scaling VSDHOne and related offerings, investing in technology and healthcare infrastructure, and supporting continued expansion across Hydreight's U.S. healthcare ecosystem.

Q2 2026 INVESTOR WEBCAST AND LIVE ANALYST Q&A

Hydreight will host an investor webcast and conference call to discuss its Q2 2026 financial results and provide an update on business operations, platform growth and strategic initiatives.

Following management's presentation, the webcast will include a live question-and-answer session with research analysts.

Date: Tuesday, September 1, 2026

Time: 6:00 a.m. Pacific Time / 9:00 a.m. Eastern Time

Webcast Registration: https://hydreight.zoom.us/webinar/register/WN_9Ibza4WgRQyvpe_Zg_wj2Q

The webcast will be hosted by Shane Madden, Chief Executive Officer of Hydreight. A replay will be made available following the event.

QUARTERLY FILINGS

The Company's condensed interim consolidated financial statements and MD&A for the three and six months ended June 30, 2026 will be available under Hydreight's issuer profile on SEDAR+.

Readers are encouraged to review the complete financial statements and MD&A in conjunction with this news release.

On behalf of the Board of Directors

Shane Madden

 Director and Chief Executive Officer

 Hydreight Technologies Inc.

About Hydreight Technologies Inc.

Hydreight Technologies Inc. is a U.S.-focused digital health infrastructure company providing technology, healthcare provider, pharmacy and compliance solutions across the United States.

Its proprietary, fully integrated platform supports a network of more than 3,000 nurses, more than 300 independent doctors and pharmacy relationships across all 50 states. The platform includes a built-in suite of integrated tools for accounting, documentation, sales, inventory, booking and managing patient data, which enables licensed healthcare professionals to provide services directly to patients at home, office or hotel.

Hydreight bridges the gap between provider compliance and patient convenience, supporting nurses, med spa technicians and other licensed healthcare professionals. The Hydreight platform allows healthcare professionals to deliver services independently or add mobile services to existing location-based operations.

Hydreight has relationships with pharmacy providers servicing all 50 states and is closely affiliated with a U.S. certified e-script and telemedicine provider network.

About VSDHOne – Direct-to-Consumer Platform

Developed in partnership with Victory Square Technologies (CSE: VST) (OTC: VSQTF) (FWB: 6F6), Hydreight Technologies launched the VSDHOne platform.

VSDHOne aims to simplify the challenges for companies and medi-spa businesses seeking to enter the online healthcare space compliantly. The platform is designed to help businesses launch direct-to-consumer healthcare brands across all 50 states.

Offerings include GLP-1s, peptides, personalized healthcare treatments, sermorelin, testosterone replacement therapy ("TRT"), hair loss, skincare, sexual health and other healthcare categories.

Hydreight has invested in technology, legal and infrastructure to launch the platform. VSDHOne provides a modular, end-to-end solution for businesses looking to launch direct-to-consumer healthcare brands, including compliance and telemedicine technology and access to nationwide doctor and pharmacy networks.

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

Use of Non-GAAP Financial Measures

The Company uses certain non-GAAP financial measures to assess its operating performance, and this press release contains non-GAAP financial measures, including "Adjusted Revenue" and "Adjusted EBITDA". These measures are not recognized under International Financial Reporting Standards ("IFRS") and do not have standardized meanings prescribed by IFRS or GAAP.

The Company defines Adjusted Revenue as gross cash income before adjustment for the deferred portion of business partner contract revenue and gross receipts from Hydreight App service sales. The Company defines Adjusted Gross Margin as GAAP gross margin plus inventory impairment plus the deferred portion of business partner contract revenue. The Company defines Adjusted EBITDA as net income (loss) before interest, taxes, depreciation and amortization and before (i) transaction, restructuring and integration costs, (ii) share-based payments expense, (iii) gains/losses that are not reflective of ongoing operating performance, including inventory impairment, and (iv) sales tax provision, net of actual cash payments to state tax authorities.

Adjusted Revenue reflects the gross economic activity processed through the Company's platform during the applicable period and may differ materially from revenue recognized under IFRS, which is based on revenue recognition and deferral requirements. Adjusted Revenue is not a measure of financial performance or profitability and should not be considered a substitute for revenue determined in accordance with IFRS. As used, Adjusted Revenue accelerates cash receipts relative to IFRS revenue recognition. Adjusted EBITDA should not be considered in isolation or as a substitute for net income (loss) prepared in accordance with IFRS.

The Company believes that these non-GAAP measures provide information useful to investors in understanding historical operating trends and the scale of the Company's platform relative to its peers but does not intend for such measures to represent future performance. This data is furnished to provide additional information and does not have any standardized meaning prescribed by IFRS. Accordingly, it should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS and is not necessarily indicative of other metrics presented in accordance with IFRS.

Cautionary Note Regarding Forward-Looking Information

This press release contains statements which constitute "forward-looking information" within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities and operating performance. Forward-looking information is often identified by the words "may", "would", "could", "should", "will", "intend", "plan", "anticipate", "believe", "estimate", "expect" or similar expressions and includes information regarding expectations for the Company's 2026 strategic outlook, growth, platform scaling initiatives, and anticipated expansion of VSDHOne and other platform offerings.

Forward‑looking information is based on management's expectations, estimates and assumptions as of the date hereof, including assumptions regarding: continued partner adoption, stable regulatory regimes applicable to telehealth and pharmacy operations in the United States, availability of capital, and general economic conditions.

Investors are cautioned that forward-looking information is not based on historical facts but instead reflects the Company's management's expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the Company.

Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: the ability to obtain requisite regulatory and other approvals with respect to the business operated by the Company and/or the potential impact of the listing of the Company's shares on the TSXV on relationships, including with regulatory bodies, employees, suppliers, customers and competitors; changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation; and the diversion of management time as a result of being a publicly listed entity. This forward-looking information may be affected by risks and uncertainties in the business of the Company and market conditions.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.

Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.

Notes:

1 "Adjusted Revenue" is a non-GAAP financial measure, and the figures reflect gross economic activity processed through the Company's platform and should not be considered revenue recognized under IFRS. See "Non-GAAP Financial Measures" section below for definition.

2 "Adjusted EBITDA" is a non-GAAP financial measure and reflects EBITDA plus additions for atypical and non-recurring charges. See "Non-GAAP Financial Measures" section below for definition.

SOURCE Hydreight Technologies Inc.

21%

more press release views with 

Request a Demo

Die LONGWELL EC-FanWall-Technologie senkt den Energieverbrauch von CRAH-Ventilatoren um 38 % in KI-Rechenzentren der nächsten Generation USA - Deutsch

NEWS PROVIDED BY

Ningbo Longwell Electric Technology Co., Ltd. (LONGWELL)

Aug 31, 2026, 22:31 ET

SHARE THIS ARTICLE

Einer der drei weltweit führenden OEM für Präzisionskühlung wechselte innerhalb von 90 Tagen von der Festlegung der Spezifikationen zur Serienproduktion; der PUE-Beitrag des CRAH-Systems verbesserte sich von einem Ausgangswert von 1,42 auf 1,28.

NINGBO, China, 1. September 2026 /PRNewswire/ -- LONGWELL (Ningbo Longwell Electric Technology Co., Ltd.), ein 1990 gegründeter, weltweit tätiger Hersteller von EC-Ventilatoren und -Motoren, hat heute sein Kühlsystem für Rechenzentren im Zeitalter der KI vorgestellt. Im Kern ermöglicht die LWBE3G-Plug-Fan-Plattform FanWall-Arrays, die den Energieverbrauch der CRAH-Ventilatoren um 38 % senken.

LONGWELL EC FanWall Technology

In Zusammenarbeit mit einem der drei weltweit führenden OEM-Hersteller für Präzisionskühlung lieferte LONGWELL innerhalb von 35 Tagen 12 Entwicklungsmuster und bestand die DV/PV-Prüfung auf Anhieb zu 100 %. Der bisherige europäische Lieferant hatte 14 Monate Entwicklungszeit plus sechs Monate Hochlaufphase veranschlagt, während LONGWELL vom Festlegen der Spezifikationen bis zur Serienfertigung nur 90 Tage benötigte. Erfasste Ergebnisse: 38 % weniger Energieverbrauch der Lüfter, 6,5 dB(A) geringerer Geräuschpegel, Senkung des PUE-Beitrags des CRAH-Systems von 1,42 auf 1,28 und keine Ausfälle im Einsatz. Die erste Bestellung des Kunden belief sich auf 1.500 Einheiten; im Rahmen eines Rahmenvertrags für den Zeitraum 2025–2027 mit einer jährlichen Mindestabnahme von 60.000 Einheiten wurden 2025 mehr als 80.000 Einheiten ausgeliefert.

Mit der zunehmenden Rechenleistung im KI-Bereich ist die Wärmedichte pro Rack innerhalb von zwei Jahren von 15–20 kW auf 60–100 kW gestiegen, wobei Plattformen der nächsten Generation bereits über 100 kW hinausgehen. LONGWELL deckt die gesamte Luftströmungskette ab: LWBE3G-EC-Steckventilatoren für CRAH/CRAC, LWAE3G-EC-Axialventilatoren für Kondensatoren und Kühltürme, mit Modbus-Steuerung, automatischer N+1-Ausfallüberbrückung und optionalen Lagervibrationssensoren, die 30–90 Tage im Voraus vor dem Ende der Lebensdauer warnen. Das vollständige, 28-seitige „Data Center Cooling Pack" ist unter https://www.longwellfans.com/solutions/data-center-cooling/ verfügbar.

„KI-Rechenleistung hat die Kühlung von Rechenzentren neu definiert", sagte Bruce Li, Gründer und CEO von LONGWELL. „Ab 60 kW pro Rack ist die Lüfterstufe nicht mehr nur eine Komponentenwahl – sie entscheidet darüber, ob ein PUE-Ziel überhaupt erreichbar ist."

Informationen zu LONGWELL: LONGWELL wurde 1990 in Yuyao, Ningbo, China, gegründet und entwickelt sowie fertigt EC- und AC-Ventilatoren und -Motoren für HLK- und industrielle Anwendungen. Das Unternehmen exportiert in mehr als 30 Länder und verfügt über eine jährliche Produktionskapazität von über 120.000 Ventilatoren für Rechenzentren. Weitere Informationen erhalten Sie unter longwellfans.com.

Die Leistungsdaten beziehen sich auf ein bestimmtes Projekt und einen bestimmten Betriebspunkt; die endgültige Auswahl sollte unter Berücksichtigung des Betriebspunkts, der Spannung/Steuerung, der Montageart und der Projektvalidierung bestätigt werden. Die vergleichenden Zeitpläne und Energiekennzahlen beziehen sich auf die im Rahmen des jeweiligen Projekts ausgetauschten Anlagen; sie implizieren weder eine geschäftliche Verbindung noch eine Billigung.

21%

more press release views with 

Request a Demo

La tecnología LONGWELL EC FanWall reduce el consumo energético de los ventiladores CRAH en un 38 % USA - español

NEWS PROVIDED BY

Ningbo Longwell Electric Technology Co., Ltd. (LONGWELL)

Aug 31, 2026, 22:35 ET

SHARE THIS ARTICLE

-La tecnología LONGWELL EC FanWall reduce el consumo energético de los ventiladores CRAH en un 38 % para centros de datos de IA de próxima generación

Uno de los tres principales fabricantes mundiales de equipos originales de refrigeración de precisión pasó de la fase de definición de especificaciones a la producción en masa en 90 días; la contribución del sistema CRAH al PUE mejoró de un valor base de 1,42 a 1,28.

NINGBO, China, 1º de setembro de 2026 /PRNewswire/ -- LONGWELL (Ningbo Longwell Electric Technology Co., Ltd.), fabricante mundial de ventiladores y motores EC fundado en 1990, presentó hoy su paquete de refrigeración para centros de datos AI-Era. La plataforma de ventiladores enchufables LWBE3G, su núcleo, permite la creación de sistemas FanWall que reducen el consumo energético de los ventiladores CRAH en un 38 %.

LONGWELL EC FanWall Technology

En colaboración con uno de los tres principales fabricantes de equipos originales (OEM) de refrigeración de precisión a nivel mundial, LONGWELL entregó 12 muestras de ingeniería en 35 días y superó las pruebas de validación de diseño y producción (DV/PV) al 100 % en el primer intento. El proveedor europeo anterior había presupuestado 14 meses de desarrollo más seis meses de puesta en marcha, mientras que LONGWELL utilizó 90 días desde la definición de las especificaciones hasta la producción en masa. Resultados registrados: reducción del 38% en el consumo energético del ventilador, 6,5 dB(A) menos ruido, contribución del PUE del sistema CRAH de 1,42 a 1,28 y cero fallos en campo. El primer pedido del cliente fue de 1.500 unidades; las entregas de 2025 superaron las 80.000 unidades en virtud de un acuerdo marco 2025-2027 con un mínimo anual de 60.000 unidades.

A medida que aumenta la capacidad de procesamiento de la IA, la densidad de calor de los racks ha pasado de 15-20 kW a 60-100 kW en dos años, y las plataformas de próxima generación superan los 100 kW. LONGWELL cubre toda la cadena de flujo de aire: ventiladores enchufables LWBE3G EC para CRAH/CRAC, ventiladores axiales LWAE3G EC para condensadores y torres de refrigeración, con control Modbus, conmutación por error automática N+1 y sensores de vibración de rodamientos opcionales que proporcionan una advertencia de fin de vida útil de 30 a 90 días. El paquete completo de refrigeración para centros de datos de 28 páginas está disponible en https://www.longwellfans.com/solutions/data-center-cooling/

"La computación con IA ha redefinido la refrigeración de los centros de datos", afirmó Bruce Li, fundador y consejero delegado de LONGWELL. "Por encima de los 60 kW por rack, la etapa del ventilador ya no es una simple elección de componentes, sino que determina si se puede alcanzar o no el objetivo de PUE".

Acerca de LONGWELL: Fundada en 1990 en Yuyao, Ningbo, China, LONGWELL diseña y fabrica ventiladores y motores EC y AC para aplicaciones industriales y de climatización (HVACR). Exporta a más de 30 países y su capacidad de producción anual para centros de datos supera las 120.000 unidades. Para más información, visite longwellfans.com.

Las cifras de rendimiento reflejan un proyecto y un punto de funcionamiento específicos; la selección final debe confirmarse mediante el punto de funcionamiento, el voltaje/control, el montaje y la validación del proyecto. Los plazos comparativos y las cifras de consumo energético se refieren al equipo sustituido en dicho proyecto y no implican ninguna afiliación ni respaldo.

21%

more press release views with 

Request a Demo